GLP-1 secretion by microglial cells and decreased CNS expression in obesity.
about
Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose ControlDPP4 deficiency preserved cardiac function in abdominal aortic banding ratsThe nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.Cardiorenal metabolic syndrome and diabetic cognopathy.Neuroinflammation in animal models of traumatic brain injury.Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson's disease.GLP-1 and weight loss: unraveling the diverse neural circuitry.Exposure to the saturated free fatty acid palmitate alters BV-2 microglia inflammatory response.Cell culture models of fatty acid overload: Problems and solutions.Tibolone Reduces Oxidative Damage and Inflammation in Microglia Stimulated with Palmitic Acid through Mechanisms Involving Estrogen Receptor Beta.Type 2 diabetes mellitus in the pathophysiology of Alzheimer's disease.Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development.The possible factors affecting microglial activation in cases of obesity with cognitive dysfunction.A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticity
P2860
Q26750746-13A5668B-9FC3-41C5-AD18-805EF517CF6EQ28538591-983B0837-DEB8-4130-9E6B-3E5E88D76794Q33600053-86799735-93C9-4528-B4F5-4A059F9654FEQ37514020-DAECEE20-792A-463E-B0CE-02ADB532B9DBQ37546147-39299335-4E43-4DAD-AF22-8C84C87514BDQ38403431-A68FF2E7-97BA-4430-A53A-79D3F57CD415Q38713935-360920CB-D76E-41EF-ABA2-9715C7D40FB7Q38794234-D3507D30-C79E-46F8-BE37-496235458350Q39120691-7B1F546E-2CA0-4753-A9F9-B1FB00AFF7D0Q46258336-A68D2E74-5E16-4C18-9C22-E5FCCAA7CC81Q46300608-B05B264F-B909-4EB9-938E-0DA22F4AFF1EQ47096119-16137016-C3D0-47FD-A60B-884E1AB2CF50Q47335504-4C4F7B1C-1727-4BB0-9AFD-F11707875E89Q47955688-CD1798CE-7779-4F44-8823-CE587E8E1DA4Q51786227-079312FF-1F47-4917-AFB4-71C90A585E04Q57101020-C36546EA-4388-42BB-AD5F-90A2982DDBA8
P2860
GLP-1 secretion by microglial cells and decreased CNS expression in obesity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
GLP-1 secretion by microglial cells and decreased CNS expression in obesity.
@ast
GLP-1 secretion by microglial cells and decreased CNS expression in obesity.
@en
type
label
GLP-1 secretion by microglial cells and decreased CNS expression in obesity.
@ast
GLP-1 secretion by microglial cells and decreased CNS expression in obesity.
@en
prefLabel
GLP-1 secretion by microglial cells and decreased CNS expression in obesity.
@ast
GLP-1 secretion by microglial cells and decreased CNS expression in obesity.
@en
P2093
P2860
P356
P1476
GLP-1 secretion by microglial cells and decreased CNS expression in obesity
@en
P2093
Camilla Kappe
Kerstin Iverfeldt
Linda M Tracy
Åke Sjöholm
P2860
P2888
P356
10.1186/1742-2094-9-276
P577
2012-12-23T00:00:00Z
P5875
P6179
1034480120